These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 11552239

  • 1. [Treatment of dyslipidemia in the secondary prevention of coronary artery disease].
    Syvänne M.
    Duodecim; 1998; 114(15):1503-8. PubMed ID: 11552239
    [No Abstract] [Full Text] [Related]

  • 2. [Critical evaluation of indications for lipid reduction. Cholesterol value updated--risk counts (interview by Dr. Kirsten Westphal)].
    Motz W.
    MMW Fortschr Med; 2003 Oct 09; 145(41):48. PubMed ID: 14655487
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of dyslipidemia].
    Cybulska B.
    Pol Merkur Lekarski; 2002 Nov 09; 13 Suppl 1():11-2. PubMed ID: 12621774
    [No Abstract] [Full Text] [Related]

  • 4. Novel approaches to the treatment of dyslipidemia.
    Rader DJ.
    Arterioscler Thromb Vasc Biol; 2005 Mar 09; 25(3):480-1. PubMed ID: 15731488
    [No Abstract] [Full Text] [Related]

  • 5. [Milestone in the treatment of diabetic dyslipidemia: the DAIS Study].
    Forster T.
    Orv Hetil; 2001 Jul 22; 142(29):1588-9. PubMed ID: 11494751
    [No Abstract] [Full Text] [Related]

  • 6. [Hyperlipidemia and arteriosclerosis].
    Mabuchi H.
    Nihon Naika Gakkai Zasshi; 1998 May 10; 87(5):950-7. PubMed ID: 9648450
    [No Abstract] [Full Text] [Related]

  • 7. Clinical aspects of dyslipidemia.
    Kashyap M.
    Manag Care; 2001 Nov 10; 10(11 Suppl):4-9; discussion 19-24. PubMed ID: 11761628
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The 2003 Canadian recommendations for dyslipidemia management: revisions are needed.
    Manuel DG, Tanuseputro P, Mustard CA, Schultz SE, Anderson GM, Ardal S, Alter DA, Laupacis A.
    CMAJ; 2005 Apr 12; 172(8):1027-31. PubMed ID: 15824409
    [No Abstract] [Full Text] [Related]

  • 10. [Primary and secondary prevention of coronary artery disease].
    Mohri M.
    Fukuoka Igaku Zasshi; 2003 Mar 12; 94(3):43-7. PubMed ID: 12784708
    [No Abstract] [Full Text] [Related]

  • 11. [What other effects do statins have except their effect on lipids?].
    Tikkanen MJ.
    Duodecim; 1998 Mar 12; 114(13):1299-301. PubMed ID: 11552256
    [No Abstract] [Full Text] [Related]

  • 12. Changing face of dyslipidemia therapy.
    Banerjee AK.
    Indian Heart J; 2008 Mar 12; 60(3):192-4. PubMed ID: 19240305
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery.
    Thielmann M, Neuhäuser M, Marr A, Jaeger BR, Wendt D, Schuetze B, Kamler M, Massoudy P, Erbel R, Jakob H.
    J Thorac Cardiovasc Surg; 2007 Nov 12; 134(5):1143-9. PubMed ID: 17976441
    [Abstract] [Full Text] [Related]

  • 17. Complications and side effects. Crestor tested in PHAs.
    TreatmentUpdate; 2005 Nov 12; 17(4):6-7. PubMed ID: 17230630
    [No Abstract] [Full Text] [Related]

  • 18. Dyslipidaemia in diabetes--a GP guide.
    Barnett AH.
    Practitioner; 2002 Feb 12; 246(1631):120-3. PubMed ID: 11852620
    [No Abstract] [Full Text] [Related]

  • 19. The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach.
    Aikawa M, Libby P.
    Cardiovasc Pathol; 2004 Feb 12; 13(3):125-38. PubMed ID: 15081469
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.